Organic Fermented Reishi Spores, Living Nutrition, 60’s

This Organic Fermented Reishi Spores uses the most nutrient-dense part of the Reishi mushroom. This offers enhanced benefits to wellbeing and defence.

• 600mg Reishi spores per serving
• Higher concentration of active triterpenes compared to the fruiting body
• Helps to support healthy environmental resistance

2 capsules provide:
Kefir-kombucha fermented Organic fermented Reishi (Ganoderma lucidum) Spores – 600mg

Each capsule contains organic Reishi spore fermented for an extended period with our signature kefir-kombucha process. Then carefully freeze dried to preserve all the unique nutrients. We then encapsulate it in an organic fermented tapioca capsule, making it uniquely 100% organic inside and out.

This product contains nutrients, enzymes, and active compounds, including friendly bacteria to produce a complete living food that gently fortifies and harmonises.

Studies shows promising therapeutic effects as an immuno-regulator and as anti-inflammatory.

Study:

This animal study shows that Reishi Spores have been effective in reducing inflammation in induced IBD colitis. This is from that study: “The compound ganoderma lucidum spore powder (GLSP) has emerged as an anti-inflammatory and anti-oxidative regulator. In this study, we explored the roles of GLSP against dextran sulfate sodium (DSS)-induced mouse colitis that can mimic human inflammatory bowel disease (IBD). GLSP was administered by oral gavage at a dosage of 150 mg/kg/day to the acute colitis mice induced by DSS. The DSS-induced mouse weight loss, colonic shortening, diarrhea and bloody stool were observably alleviated after GLSP treatment.

The lesion of macroscopic and microscopic signs of the disease decreased significantly. Gut barrier dysfunction improved via increasing the level of claudin-1, ZO1, Occu, and ZO2 with GLSP. Meanwhile, the levels of IL-6, TNF-α, IL-1β, and IL-18 in the colon improved in the GLSP-treated groups. In addition, phosphorylation of the MAPKs. ERK1/2, p38, and AKT was suppressed after GLSP treatment. All these results demonstrated that GLSP owned a protective effect on DSS-induced colitis by inhibition of MAPK pathway, which provides a promising therapeutic approach for the treatment of colitis.”